Study of STI-3031 in Patients With Selected Relapsed or Refractory Solid Tumors

Clinical trial NCT04809012 · WITHDRAWN

Trial details

NCT number: NCT04809012
Sponsor: Sorrento Therapeutics, Inc.
Status: WITHDRAWN
Phase: Phase 2
Study type: INTERVENTIONAL

Solid Tumor Refractory Tumor Relapsed Solid Tumor

Start date: 2021-06-01
Primary completion: 2024-06-01
Enrollment: 0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.